I agree that this site is using cookies. You can find further informations here.
X
Kartman, B.
18  results:
Search for persons X
?
1

PDB50 DOES THE APPLICATION OF UKPDS RISK EQUATIONS UNDEREST..:

McEwan, P. ; Bennett, H. ; Kartman, B....
Value in Health.  22 (2019)  - p. S581 , 2019
Link: https://doi.org/10.1016/..
 
?
2

PDB44 - THE HEALTH ECONOMIC VALUE OF SHORT-TERM CARDIOVASCU..:

Ward, T. ; Bennett, H. ; McEwan, P....
Value in Health.  21 (2018)  - p. S125 , 2018
Link: https://doi.org/10.1016/..
 
?
3

A Systematic Literature Review of the Epidemiology and Econ..:

Sanyal, A.J. ; Martin, A.L. ; Cadarette, S.M....
Journal of Hepatology.  64 (2016)  2 - p. S475 , 2016
Link: https://doi.org/10.1016/..
 
?
4

Exenatide Once Weekly Plus Metformin for the Treatment of T..:

Kayaniyil, S ; Lozano-Ortega, G ; Bennett, H...
Value in Health.  18 (2015)  7 - p. A597-A598 , 2015
Link: https://doi.org/10.1016/..
 
?
5

Cost-Effectiveness Analysis of Exenatide Once-Weekly Versus..:

Charokopou, M ; Chuang, L ; Verheggen, B...
Value in Health.  18 (2015)  7 - p. A606 , 2015
Link: https://doi.org/10.1016/..
 
?
6

The Cost-Effectiveness of Exenatide Bid Versus Insulin Lisp..:

Gordon, J. ; McEwan, P. ; Sabale, U..
Value in Health.  17 (2014)  7 - p. A344 , 2014
Link: https://doi.org/10.1016/..
 
?
7

PGS13 HEALTH STATE UTILITIES AND WILLINGNESS TO PAY IN GERD..:

Kartman, B
Value in Health.  5 (2002)  6 - p. 505 , 2002
Link: https://doi.org/10.1016/..
 
?
8

PDG27: HEALTH STATE UTILITIES IN GERD PATIENTS WITH HEARTBU..:

Kartman, B ; Gatz, G ; Johannesson, M
Value in Health.  4 (2001)  6 - p. 512-513 , 2001
Link: https://doi.org/10.1016/..
 
?
9

Within-trial evaluation of medical resources, costs, and qu..:

Reed, S ; Li, Y ; Dakin, H...
doi:10.2337/dc19-0950.  , 2019
Link: https://doi.org/10.2337/..
 
?
10

EXSCEL—once-weekly exenatide reduces medical resource utili..:

Reed, S ; Li, Y ; Dakin, H...
doi:10.2337/db18-1319-P.  , 2019
Link: https://doi.org/10.2337/..
 
?
11

Impact of exenatide on medical costs and health utilities i..:

Reed, S ; Li, Y ; Dakin, H...
doi:10.1007/s00125-018-4693-0.  , 2018
Link: https://doi.org/10.1007/..
 
?
12

Lifetime cost-effectiveness simulation of exenatide once-we..:

Becker, F ; Dakin, H ; Reed, S...
doi:10.1007/s00125-018-4693-0.  , 2018
Link: https://doi.org/10.1007/..
 
?
13

Efficacy and safety of baricitinib plus standard of care fo..:

Ely, E Wesley ; Ramanan, Athimalaipet V ; Kartman, Cynthia E...
The Lancet Respiratory Medicine.  10 (2022)  4 - p. 327-336 , 2022
Link: https://doi.org/10.1016/..
 
?
14

LB3. Baricitinib plus Standard of Care for Hospitalized Adu..:

Ely, E Wesley ; Ramanan, Athimalaipet V ; Kartman, Cynthia E...
Open Forum Infectious Diseases.  8 (2021)  Supplement_1 - p. S808-S809 , 2021
Link: https://doi.org/10.1093/..
 
?
15

Book reviews:

Peters, Aribert B. ; Salter, Christopher L. ; Polese, Mario...
The Annals of Regional Science.  16 (1982)  2 - p. 85-137 , 1982
Link: https://doi.org/10.1007/..
 
1-15